Institute for Advanced Academic Research / Chiba University Hospital Allergy and Clinical Immunology | M.D., Ph.D.
01
TLR7-related diseasesMonogenic diseaseAutoimmunityTranslational research
02 / RESEARCH
Research Themes
We begin with genetic clues found in patients, establish causal mechanisms experimentally, and translate them into therapy.
01TLR7 & AUTOIMMUNITY
TLR7 and Autoimmunity
Why does an immune sensor turn against the self?
Starting from gain-of-function TLR7 variants identified in severe SLE, we investigate how altered response thresholds and RNA-ligand recognition drive autoimmunity in human cells and disease models.
SLE
TLR7
RNA sensing
ligand specificity
02MONOGENIC IMMUNE DISEASE
Monogenic Immune Diseases
Reading the principles of human immunity from a single variant.
We analyze patient genomes in inborn errors of immunity and immune dysregulation, then test candidate variants at the molecular and cellular levels. Our aim extends beyond diagnosis to the principles of host defense and immune homeostasis.
IEI
clinical genomics
variant interpretation
SBNO2 / BTK
03TRANSLATIONAL IMMUNOLOGY
From Clinic to Mechanism and Therapy
Turning rare cases into the next diagnosis and treatment.
We move iteratively among clinical phenotypes, whole-exome sequencing, functional assays, disease models, and omics to establish causal chains in disease, while accounting for differences between humans and model organisms.
WES
functional validation
disease model
single-cell
01CLINICPhenotype
02GENEVariant discovery
03MECHANISMFunctional testing
04MODELDisease modeling
05TRANSLATIONDiagnosis & therapy
03 / FOR THE PUBLIC
From one patient to the next therapy.
The immune system protects us from bacteria and viruses. But when it responds too strongly—or targets the wrong thing—it can damage our own bodies and cause immune disease.
We use small genetic differences found in patients as clues, test how disease develops, and work toward new diagnostic and therapeutic approaches. Rare-disease research takes time and sustained support. Donations help fund genetic analysis, experiments in cells and disease models, and the work needed to bring therapeutic candidates closer to patients.
Analyze genesEstablish causalityAdvance therapy
When donating through the Chiba University Future Medical Fund, please enter both “目黒免疫遺伝子研究” and “アレルギー臨床免疫学 目黒和行” as the designated use of funds.
2024Chiba University Future Medical Fund Research GrantDeveloping new therapies for autoimmune disease from whole-exome sequencing of patients with immune disorders
2023Young Investigator’s Poster Award (Clinical)The 2nd International Symposium of Clinical Immunology
2022NIH Fellows Award for Research Excellence (FARE) 2023National Institutes of Health
2018JSPS Overseas Research FellowshipNational Institutes of Health, USA
F / FUNDING
Funding
2025–27JSPS KAKENHI Grant-in-Aid for Scientific Research (B) | Co-investigatorThe role of nucleic-acid metabolism in autoimmune and autoinflammatory diseases
2026–28JSPS KAKENHI Grant-in-Aid for Scientific Research (C)Genetic evidence linking altered TLR7 ligand specificity to SLE
2023–24JSPS KAKENHI Transformative Research Areas (A)Self-directed immunity: immune-sensor mislocalization and human autoimmune disease
2023–25JSPS KAKENHI Grant-in-Aid for Scientific Research (C)A novel TLR7 variant in severe juvenile SLE and its disease mechanism
2024–25Chiba University Future Medical Fund Research GrantDeveloping new therapies for autoimmune disease from whole-exome sequencing of immune-disease patients
2023–28Takeda Science Foundation Medical Research Grant and Continuation Grant (Clinical)A therapeutic platform inspired by a gain-of-function TLR7 variant from severe SLE
2022–24JSPS KAKENHI Grant-in-Aid for Early-Career Scientists — Start-upMolecular regulation of SBNO2, a newly identified immune-dysregulation gene
2016–17JSPS KAKENHI Grant-in-Aid for Young Scientists (B)Differentiation of iTR35 cells and their role in rheumatoid arthritis
P / PRESENTATIONS
Presentations
2024Unwinding the molecular pathogenesis of a novel inherited immunodysregulatory disorder caused by loss-of-function mutations in DExD/H box helicase SBNO2The 5th Asia-Pacific Society for Immunodeficiency (APSID) Congress 2024
2023SBNO2 deficiency, a novel inherited immunodysregulatory syndrome, reveals new molecular mechanisms in host defensesThe 9th Global Network Forum on Infection and Immunity: Neo Mycology — Invited
2022Unwinding the molecular pathogenesis of a novel inherited immunodysregulatory disorder caused by loss-of-function mutations in DExD/H box helicase SBNO2The 51st Annual Meeting of the Japanese Society for Immunology — Symposium
2015Roles of B Cell Leukemia/Lymphoma 3 in the Development of T Follicular Helper Cells and the Pathogenesis of Rheumatoid ArthritisEULAR Congress 2015 — Rome, Italy